Weizmann Institute

FDA approval

Cop 1 (Copaxone®): The Story of a Drug

Cop 1 (Copaxone®): The Story of a Drug

01.05.1997

Disease, Drugs & Diagnostics

Nearly three decades after a surprising discovery, Copaxone® gets FDA approval for the treatment of MS

New Drug for Multiple Sclerosis Approved by the U.S. Food and Drug Administration

New Drug for Multiple Sclerosis Approved by the U.S. Food and Drug Administration

23.12.1996

Disease, Drugs & Diagnostics

REHOVOT, Israel -- December 23, 1996 -- The U.S. Food and Drug Administration today announced the approval of the Israeli...

New Drug for Multiple Sclerosis Receives Recommendation of a U.S. Food And Drug Administration Advisory Committee

New Drug for Multiple Sclerosis Receives Recommendation of a U.S. Food And Drug Administration Advisory Committee

19.09.1996

Disease, Drugs & Diagnostics

REHOVOT, Israel -- September 19, 1996 -- An advisory committee convened by the U.S. Food and Drug Administration...

Top Stories

See All >

electrons flowing in graphene

Electrons Caught Flowing like Water for the First Time

Blue-Sky Dye Spells Hope for Improving Heart Function

New Molecules Precisely Target Mutant Disease Gene

Prof. Ron Naaman

Prof. Ron Naaman

Press Releases

See All >

Electrons Caught Flowing like Water for the First Time

The 11th President of the Weizmann Institute and Four New Vice Presidents Take Office

The Greenest Diet: Bacteria Switch to Eating Carbon Dioxide

Most Popular Articles

The Coin Toss Paradox

Can a game with “quantum” rules beat the odds?

Checking the Dosage

Prof. Yoram Groner is a pioneer in Down syndrome research

Prof. Zvi Artstein, Vice President for Technology Transfer

Prof. Zvi Artstein